| 1. | | Recruiting | Benzydamine in Treating Radiation-Induced Oral Mucositis in Patients Who Are Undergoing Radiation Therapy for Cancer of the Oral Cavity, Oropharynx, and/or Nasopharynx
Conditions: lip and oral cavity cancer; Nasopharyngeal Cancer; oral complications of chemotherapy and head and neck radiation; Oropharyngeal Cancer |
| 2. | | Recruiting | RK-0202 in Preventing Oral Mucositis in Patients Who are Undergoing Radiation Therapy for Cancer of the Mouth, Throat, or Salivary Glands
Conditions: lip and oral cavity cancer; Nasopharyngeal Cancer; oral complications of cancer and cancer therapy; Oropharyngeal Cancer; radiation toxicity; ... |
| 3. | | Recruiting | Zinc Sulfate in Preventing Loss of Sense of Taste in Patients Undergoing Radiation Therapy for Head and Neck Cancer
Conditions: Head and Neck Cancer; oral complications of cancer and cancer therapy; radiation toxicity |
| 4. | | Recruiting | Cevimeline in Treating Patients With Dry Mouth Caused by Radiation Therapy for Head and Neck Cancer
Conditions: Hypopharyngeal Cancer; Laryngeal Cancer; lip and oral cavity cancer; metastatic squamous neck cancer with occult primary; Nasopharyngeal Cancer; ... |
| 5. | | Recruiting | Bortezomib Followed by the Addition of Doxorubicin at Disease Progression in Treating Patients With Locally Advanced, Recurrent, or Metastatic Adenoid Cystic Carcinoma (Cancer) of the Head and Neck
Conditions: lip and oral cavity cancer; Salivary Gland Cancer |
| 6. | | Recruiting | 17-DMAG in Treating Patients With Metastatic or Unresectable Solid Tumors
Condition: Cancer |
| 7. | | Recruiting | Bevacizumab, Fluorouracil, and Hydroxyurea Plus Radiation Therapy in Treating Patients With Advanced Head and Neck Cancer
Condition: Head and Neck Cancer |
| 8. | | Recruiting | Capecitabine Combined with Cisplatin in Treating Patients With Locally Advanced or Metastatic Solid Tumors
Conditions: Breast Cancer; Gastrointestinal Cancer; Head and Neck Cancer; thorax and respiratory cancer; unclassified and other cancer |
| 9. | | Recruiting | Chemotherapy in Treating Patients With Refractory Advanced Solid Tumors or Hematologic Cancer
Condition: Cancer |
| 10. | | Recruiting | Gefitinib in Treating Patients With Metastatic or Unresectable Head and Neck Cancer or Non-Small Cell Lung Cancer
Conditions: Head and Neck Cancer; thorax and respiratory cancer |
| 11. | | Recruiting | Thalidomide and Docetaxel in Treating Patients With Advanced Cancer
Condition: Cancer |
| 12. | | Recruiting | UCN-01 and Irinotecan in Treating Patients With Metastatic or Unresectable Solid Tumors
Condition: Cancer |
| 13. | | Recruiting | Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction
Condition: Cancer |
| 14. | | Recruiting | Photodynamic Therapy in Treating Patients With Skin Cancer or Solid Tumors Metastatic to the Skin
Conditions: adult solid tumor; Breast Cancer; Head and Neck Cancer; hematopoietic and lymphoid cancer; skin tumor |
| 15. | | Recruiting | Combination Chemotherapy Plus Filgrastim in Treating Patients With Advanced Solid Tumors
Condition: Cancer |
| 16. | | Recruiting | Cisplatin or Carboplatin Combined With Gemcitabine in Treating Patients With Locally Advanced, Recurrent, or Metastatic Malignant Salivary Gland Tumor
Conditions: high-grade salivary gland carcinoma; low-grade salivary gland carcinoma; Salivary Gland Cancer |
